Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 16 AL 30

Neuropathology of depression in Alzheimer's disease: current knowledge and the potential for new treatments

Khundakar AA, Thomas AJ.

J Alzheimers Dis. 2015;44(1):27-41. doi: 10.3233/JAD-148003.

Vitamin D and cognition in older adults: an update of recent findings

Brouwer-Brolsma EM, de Groot LC.

Curr Opin Clin Nutr Metab Care. 2015 Jan;18(1):11-6. doi: 10.1097/MCO.0000000000000114.

Towards a unified vision of copper involvement in Alzheimer's disease: a review connecting basic, experimental, and clinical research

Pal A, Siotto M, Prasad R, Squitti R.

J Alzheimers Dis. 2015;44(2):343-54. doi: 10.3233/JAD-141194.

Differential alterations of neocortical GluN receptor subunits in patients with mixed subcortical ischemic vascular dementia and Alzheimer's disease

Mohamed NE, Lee JH, Francis PT, Esiri MM, Chen CP, Lai MK.

J Alzheimers Dis. 2015;44(2):431-7. doi: 10.3233/JAD-141764.

The mechanical cause of age-related dementia (Alzheimer's disease): the brain is destroyed by the pulse

Stone J, Johnstone DM, Mitrofanis J, O'Rourke M.

J Alzheimers Dis. 2015;44(2):355-73. doi: 10.3233/JAD-141884.

More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease

Möller C, Dieleman N, van der Flier WM, Versteeg A, Pijnenburg Y, Scheltens P, Barkhof F, Vrenken H.

J Alzheimers Dis. 2015;44(2):635-47. doi: 10.3233/JAD-141230.

Cognitive profiles and neuropsychiatric symptoms in Korean early-onset Alzheimer's disease patients: a CREDOS study

Park HK, Choi SH, Park SA, Kim HJ, Lee Y, Han SH, Kim EJ, Kim BC, Han HJ, Moon SY, Yang DW, Park KW, Park KH, Yoon B, Seo SW, Na DL, Na HR, Lee JH.

J Alzheimers Dis. 2015;44(2):661-73. doi: 10.3233/JAD-141011.

Caspases: therapeutic targets in neurologic disease

Troy CM, Jean YY.

Neurotherapeutics. 2015 Jan;12(1):42-8. doi: 10.1007/s13311-014-0307-9.

Age Progression of Neuropathological Markers in the Brain of the Chilean Rodent Octodon degus, a Natural Model of Alzheimer's Disease

Inestrosa NC, Ríos JA, Cisternas P, Tapia-Rojas C, Rivera DS, Braidy N, Zolezzi JM, Godoy JA, Carvajal FJ, Ardiles AO, Bozinovic F, Palacios AG, Sachdev PS.

Brain Pathol. 2015 Nov;25(6):679-91. doi: 10.1111/bpa.12226. Epub 2015 Feb 10.

Biometals and their therapeutic implications in Alzheimer's disease

Ayton S, Lei P, Bush AI.

Neurotherapeutics. 2015 Jan;12(1):109-20. doi: 10.1007/s13311-014-0312-z.

Systematic review of the relationship between amyloid-β levels and measures of transgenic mouse cognitive deficit in Alzheimer's disease

Foley AM, Ammar ZM, Lee RH, Mitchell CS.

J Alzheimers Dis. 2015;44(3):787-95. doi: 10.3233/JAD-142208.

Exploring the epigenetics of Alzheimer disease

Traynor BJ, Renton AE.

JAMA Neurol. 2015 Jan;72(1):8-9. doi: 10.1001/jamaneurol.2014.3057.

Phosphodiesterase-4 (PDE4) molecular pharmacology and Alzheimer's disease

Gurney ME, D'Amato EC, Burgin AB.

Neurotherapeutics. 2015 Jan;12(1):49-56. doi: 10.1007/s13311-014-0309-7.

β-Amyloid peptides and amyloid plaques in Alzheimer's disease

Gouras GK, Olsson TT, Hansson O.

Neurotherapeutics. 2015 Jan;12(1):3-11. doi: 10.1007/s13311-014-0313-y.

Cerebral circulation: function and dysfunction in Alzheimer's disease

Hamel E.

J Cardiovasc Pharmacol. 2015 Apr;65(4):317-24. doi: 10.1097/FJC.0000000000000177.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias